Wednesday, March 25, 2015

EyewireTV — Actavis Completes Allergan Acqusition, EVA FDA Approval

In this week's EyewireTV, Actavis completes its acquisition of Allergan in a transaction valued at about $70.5 billion in cash and equity; and DORC receives FDA approval for the EVA integrated vitrectomy and phaco system. In the feature, leading ophthalmologists discuss how private practices and academic programs affect drug and product innovation. (1085 Views)

Watch Video

Wednesday, March 18, 2015

New Clinical Findings for Cataract and Glaucoma Drug Candidates

In this week’s EyewireTV, Ocular Therapeutix announces positive topline data from a phase 3a clinical trial evaluating the safety and efficacy of its drug candidate, OTX-DP, for the treatment of ocular inflammation and pain following cataract surgery; and preclinical research by Aerie Pharmaceuticals shows that the company’s lead drug candidate, Rhopressa, has the potential to modify the course of glaucoma by arresting fibrosis. (1440 Views)

Watch Video

Wednesday, March 11, 2015

EyewireTV - LessDrops Evaluation Results, US Drug Spending Soars

In this week's EyewireTV, Imprimis Pharmaceuticals and the Cleveland Eye Clinic announce preliminary results of an investigator-initiated evaluation examining the use of the company's proprietary LessDrops formulation; and Drug spending in the United States rose last year at the fastest rate in more than a decade, driven by soaring demand and price increases for specialty agents. Also, Carl Zeiss Meditec launches its next-generation perimetry system, the Humphrey Field Analyzer 3. (1990 Views)

Watch Video

Wednesday, March 04, 2015

EyewireTV — Dry Eye Treatment NDA, AECOS Winter Symposium

In this week's EyewireTV, Shire submits a new drug application to the FDA for its investigational dry eye treatment lifitegrast; and following FDA approval, Alimera Sciences begins shipping its diabetic macular edema treatment Iluvien (fluocinolone acetonide). Also, physicians and industry members at the AECOS Winter Symposium in Aspen discuss the most significant takeaway messages from the meeting. (1558 Views)

Watch Video

Wednesday, February 25, 2015

EyewireTV — FDA Advisory Committee Recommends Approval of Avedro's Cross-Linking Platform

In this week’s EyewireTV, a joint FDA advisory panel recommends approval of Avedro’s combined riboflavin ophthalmic solutions and ultraviolet light irradiation for corneal collagen cross-linking; and Valeant agrees to acquire Salix Pharmaceuticals, a maker of gastrointestinal drugs, in anall cash deal valued at about $10.1 billion. Also, a large study shows that laser cataract surgery and standard phacoemulsification are equally safe procedures. (1612 Views)

Watch Video

Thursday, February 19, 2015

EyewireTV — Protocol T Study Results, Avedro Cross-Linking FDA Hearing

Results of the government-sponsored Protocol T study show that three agents used to treat diabetic macular edema were effective and safe, however, the relative effect correlated with patients’ baseline visual acuities; and a date is set for an FDA advisory panel to review Avedro’s new drug application for its corneal cross-linking platform. (2231 Views)

Watch Video

Wednesday, February 11, 2015

EyewireTV — Lucentis DR Approval, Caribbean Eye Highlights

In this week's EyewireTV, the FDA expands the approved use of Lucentis (ranibizumab) to treat diabetic retinopathy in patients with diabetic macular edema; and results of an international study show that the InnFocus MicroShunt implant lowered IOP and reduced reliance on glaucoma medication. Also, the annual Caribbean Eye meeting takes place in San Juan, Puerto Rico. Co-chair Dee Stephenson, MD, talks about the highlights of the meeting and what’s in store for next year. (1543 Views)

Watch Video

Wednesday, February 04, 2015

EyewireTV — New Glaucoma System, Pazeo FDA Approval, Tecnis Multifocal IOLs

In this week’s EyewireTV, Iridex is granted FDA 510(k) clearance for the Cyclo G6 Laser System for the treatment of multiple stages of glaucoma; and Alcon receives FDA approval for Pazeo (olopatadine hydrochloride ophthalmic solution) 0.7% for the treatment of ocular itching associated with allergic conjunctivitis. Also, Abbott Medical Optics announces that two new Tecnis multifocal IOLs (+2.75 D and +3.25 D) have received FDA approval. (2221 Views)

Watch Video

Wednesday, January 28, 2015

EyewireTV — Ophthalmic Pioneer George Waring III Passes Away at Age 73

In this week’s EyewireTV, ophthalmic pioneer George Waring III, MD, FACS, FRCOphth, who was influential in getting excimer laser vision correction surgery approved in the United States, passes away at the age of 73; and Abbott Medical Optics announces FDA clearance for the creation of intracorneal pockets with the iFS Advanced Femtosecond Laser System. Also, Regeneron announces that Eylea has been recommended for approval in Europe for the treatment of visual impairment due to macular edema secondary to central or branch retinal vein occlusion. (2674 Views)

Watch Video

Wednesday, January 21, 2015

EyewireTV — Victus Upgrades, Eidon US Launch

In this week's EyewireTV, Bausch + Lomb receives FDA 510(k) clearance for an advanced swept-source OCT imaging system and updated software for its Victus Femtosecond Laser Platform, and at the Royal Hawaiian Eye Meeting in Maui, CenterVue announces the US launch of the Eidon imaging system. Also, InnFocus provides updates on its MicroShunt glaucoma drainage implant. (2712 Views)

Watch Video

Wednesday, January 14, 2015

EyewireTV — New Postoperative Drop Formulation, 5-Year Cataract Surgery Study

In this week's EyewireTV, Imprimis Pharmaceuticals plans to introduce LessDrops, a proprietary eye drop formulation to be administered following laser refractive and cataract surgery; and a large, 5-year study examining trends in cataract surgery shows decreasing visual thresholds for surgery, decreasing surgical complication rates, and increasing visual outcomes. Also, Synergetics USA acquires Sterimedix, a provider of single-use ophthalmic instruments, in a deal worth up to $13.5 million. (3148 Views)

Watch Video

Wednesday, January 07, 2015

EyewireTV — 2014 FDA Drug Approvals, Digital Eye Strain

In this week's EyewireTV, the FDA’s drug approval rate hit an 18-year high in 2014 as the agency gave the green light to 44 new medicines; and new research shows that nearly 95% of Americans spend 2 or more hours every day on digital devices, highlighting the need to address the rising occurrence of eye strain. Also, Nidek announces the launch of the Retina Scan Duo, a device that combines high-definition OCT and fundus camera capabilities. (2072 Views)

Watch Video
Load More